| 4FYN | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 0VE | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Rational design of highly selective spleen tyrosine kinase inhibitors., Lucas MC, Goldstein DM, Hermann JC, Kuglstatter A, Liu W, Luk KC, Padilla F, Slade M, Villasenor AG, Wanner J, Xie W, Zhang X, Liao C, J Med Chem. 2012 Dec 13;55(23):10414-23. doi: 10.1021/jm301367c. Epub 2012 Nov, 27. PMID:23151054 | ||||||||||||||
| Data retrieval |
![]() |
| View 4FYN in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |